Patents Assigned to CELLIS AG
  • Cellular targeted label delivery system
    Patent number: 12485192
    Abstract: The present invention relates to an isolated cellular targeted delivery system comprising a CD45+ leukocyte cell comprising within said cell a complex of one or more iron binding proteins and/or a label as well as methods for producing such isolated cellular targeted delivery system and uses of such system for therapy diagnosis and in particular for diagnosis of cancer, particularly metastatic cancer, in particular for therapy of cancer.
    Type: Grant
    Filed: June 29, 2021
    Date of Patent: December 2, 2025
    Assignee: CELLIS AG
    Inventors: Magdalena Krol, Irene Benni, Paola Baiocco, Tomasz Rygiel, Alberto Boffi